West African Emerging Infectious Disease Research Center (WA-EIDRC)
Project Number3U01AI151812-02S1
Contact PI/Project LeaderANDERSEN, KRISTIAN GRAUGAARD
Awardee OrganizationSCRIPPS RESEARCH INSTITUTE, THE
Description
Abstract Text
Ensuring a world safe from microbial threats is a pressing challenge, as outbreaks exact tolls on human
health, disrupt regional security, and have the potential to rapidly escalate into global crises. In recent
years, severe outbreaks of Ebola, Lassa, Zika, and other emerging viruses have illustrated how vulnerable
the world is to threats from RNA viral pathogens. These public health emergencies have exposed the
urgent need for improved infrastructure, scientific knowledge, and diagnostic tools in areas of the world
most at risk, and underscore the need for proactive pathogen surveillance, detection, and discovery.
West Africa has a disproportionate vulnerability to outbreaks, but we lack awareness of acute threats,
their natural history, and effective strategies for prevention. Rooted research between local and global
partners, combined with novel assays and strategies for pandemic preparedness is required to answer
these questions. We will build the capacity to rapidly respond to future outbreaks by establishing the
West African Emerging Infectious Disease Research Center. This center will expand on years of successful
cross-disciplinary research and capacity building, bringing together leading researchers from the United
States, Liberia, Nigeria, Senegal, and Sierra Leone. We will: (1) perform comprehensive surveys of acute
RNA viral disease and determine critical threats circulating in hosts and reservoirs; (2) identify risk factors
of virus transmission and evolution; (3) dissect pathogenesis and natural history of severe RNA viral
diseases; and (4) determine diagnostic criteria for infection outcome to guide public health interventions.
Our work will significantly expand research capacity in West Africa via technology development of novel
solutions for surveillance, diagnostics, and pathogen discovery. By establishing our center with a focus on
priority pathogen research, technology transfer, training, and capacity building, we will develop flexible
strategies for detecting, mitigating, and preventing the emergence of future infectious disease outbreaks.
Public Health Relevance Statement
In recent years, severe outbreaks and epidemics of Ebola, Lassa, and Zika have illustrated how vulnerable
the world is to threats from RNA viral pathogens. To counter the dangers posed by these viruses, we
must develop flexible and scalable technologies for diagnostics, surveillance, pathogen discovery and
transmission, and deploy them in the most outbreak-prone regions of the world. Here, we will establish
the West African Emerging Infectious Diseases Research Center with partners in the United States,
Senegal, Sierra Leone, Liberia, and Nigeria, to develop effective strategies, and deploy the necessary
tools, for detecting, mitigating, and preventing future outbreaks from emerging and re-emerging
infectious diseases.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AcuteAffectAfricaAfricanAnimalsAreaAwarenessBiological AssayChiropteraClinicalClinical ManagementClustered Regularly Interspaced Short Palindromic RepeatsCollaborationsCommunicable DiseasesCommunicationCommunitiesCountryDecentralizationDetectionDevelopmentDiagnosticDiagnostic testsDisease OutbreaksEbolaEducational workshopEmerging Communicable DiseasesEnsureEpidemicEpidemiologistEvolutionFoundationsFrequenciesFundingFutureGenomicsGoalsHealthHumanImmune responseInfectionInfectious Diseases ResearchInfrastructureKnowledgeLassa virusLiberiaMetagenomicsMethodsMolecular EpidemiologyNational Institute of Allergy and Infectious DiseaseNatural HistoryNigeriaOutcomePathogenesisPatientsPlant RootsPrevalencePrevention strategyProtocols documentationPublic HealthRNARNA VirusesRapid diagnosticsReagentResearchResearch PersonnelRiskRisk FactorsRodentSecuritySenegalSierra LeoneStandardizationSurveysSystemTechnology TransferTestingTrainingUnited StatesUnited States National Institutes of HealthViral Hemorrhagic FeversVirusVirus DiseasesWorkWorld BankZIKAbasecohortcomputerized toolsdata sharingdiagnostic assaydiagnostic technologiesemerging pathogenexperienceflexibilitygenome sequencingimprovedmetagenomic sequencingmicrobialnew technologynovelpandemic diseasepandemic preparednesspathogenpathogenic viruspreventpriority pathogenpublic health emergencypublic health interventionresponsesurveillance studytechnology developmenttooltransmission processviral transmission
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
781613492
UEI
PHZJFZ32NKH4
Project Start Date
17-August-2021
Project End Date
30-April-2023
Budget Start Date
17-August-2021
Budget End Date
30-April-2023
Project Funding Information for 2021
Total Funding
$266,250
Direct Costs
$150,000
Indirect Costs
$116,250
Year
Funding IC
FY Total Cost by IC
2021
National Institute of Allergy and Infectious Diseases
$266,250
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 3U01AI151812-02S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3U01AI151812-02S1
Patents
No Patents information available for 3U01AI151812-02S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3U01AI151812-02S1
Clinical Studies
No Clinical Studies information available for 3U01AI151812-02S1
News and More
Related News Releases
No news release information available for 3U01AI151812-02S1
History
No Historical information available for 3U01AI151812-02S1
Similar Projects
No Similar Projects information available for 3U01AI151812-02S1